Coustan-Smith et al. introduced 22 new markers (CD44, BCL2, HSPB1, CD73, CD24, CD123, CD72, CD86, CD200, CD79b, CD164, CD304, CD97, CD102, CD99, CD300a, CD130, PBX1, CTNNA1, ITGB7, CD69, CD49f), which were expressed in 81.4% of ALL cases. The gene discussed is CD69; the disease is acute lymphoblastic leukemia.